OCM
OMCL icon

Osterweis Capital Management’s Omnicell OMCL Stock Holding History

Osterweis Capital Management’s Portfolio OMCL Stock Details OMCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-75,420
Closed -$6.56M – 252
2022
Q3 		$6.56M Buy
75,420
+38,250
+103% +$4.02M 0.49% 58
2022
Q2 		$4.23M Sell
37,170
-30,620
-45% -$3.51M 0.32% 78
2022
Q1 		$8.78M Buy
+67,790
New +$9.77M 0.48% 71

Other funds holding OMCL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.36B AUM 17.81% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

Osterweis Capital Management's OMCL Position: Q4 2022 in Review

Osterweis Capital Management sold out of Omnicell (OMCL) in Q4 2022, closing a stake of 75,420 shares — an estimated $6.56M sold.

Osterweis Capital Management first reported a position in OMCL in Q1 2022 and held it in 3 quarters. The position peaked at $8.78M in Q1 2022. 328 funds tracked by Wall St. Rank hold OMCL as of Q4 2022.

  • Osterweis Capital Management reported no remaining Omnicell position as of Q4 2022 after selling out during the quarter.
  • Osterweis Capital Management sold 75,420 Omnicell shares in Q4 2022, an estimated $6.56M.
  • Osterweis Capital Management first reported a position in Omnicell in Q1 2022 and held it in 3 quarters.
  • Osterweis Capital Management's Omnicell position peaked at $8.78M in Q1 2022.
  • 328 funds tracked by Wall St. Rank held Omnicell as of Q4 2022.

Based on Osterweis Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.